In order to fully understand the innovative R&D concepts, advanced technology platforms and diversified business operation models of member units, at the beginning of the new year in 2024, a team led by Feng Lan, secretary-general of our association, and heads of relevant business departments visited Beijing Kexin Bicheng Pharmaceutical Technology Development Co., Ltd. (hereinafter referred to as Kexin Bicheng) conducts close communication and exchanges with member units.

Han Ye, Chairman of Kexin Bicheng, talked about the company's development history, focusing on the development of technology platforms, The research pipeline and other aspects will be introduced in detail. Kexin Bicheng has always been committed to the research and development and technological innovation of pharmaceutical preparations. It has built advanced high-end preparation technology platforms such as sustained and controlled release, providing preparation research and development services to domestic pharmaceutical companies and scientific research institutions, and accelerating the substitution of imported drugs and independent innovation. At present, the company has deployed multiple product pipelines focusing on children's medicines and rare disease medicines, among which water-free swallowable granule preparations and micro-tablet preparation technologies have filled the gaps in my country. In November 2023, Kexinbicheng's first domestic innovative preparation, ambroxol hydrochloride direct-administered granules, was approved for marketing, providing a new direction for clinical problems such as poor medication compliance and many safety hazards in children.

Secretary-General Feng Lan said: The clinical diagnosis, treatment and medication issues of children and rare disease patients have always been an important direction of concern of the China Pharmaceutical Promotion Association, and by promoting the close integration of "industry, academia, research and funding", the relevant Policy formulation and implementation. At the same time, we are also very pleased to see that Kexin Bicheng has "sharpened its sword for ten years" and achieved a milestone development in the launch of innovative products. Our association will also create a good environment and cooperation for member units' own development and cooperation among members. condition.

Kexin Bicheng was established in Zhongguancun Science and Technology Park in 2003. It is a company focusing on oral administration. A national high-tech enterprise that provides services for technological innovation and industrialization transfer of solid pharmaceutical preparations. The company adheres to market orientation and industrialization as its goal, and obtains independent intellectual property rights and commercial value as the standard for measuring innovation results. It is committed to research, development and technological innovation in the field of pharmaceutical preparations, and builds domestic advanced oral drug speed, slowness and control. It will establish a technology innovation system for pharmaceutical preparations such as drug release, achieve international standards for China's pharmaceutical preparation technology and products, and lead the internationalization of China's pharmaceutical industry.